申请人:E. R. Squibb & Sons, Inc.
公开号:US05212164A1
公开(公告)日:1993-05-18
Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthesis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents are provided which have the structure ##STR1## wherein m is 0, 1, 2 or 3; n is 0, 1, 2, 3 or 4; Y.sup.1 and Y.sup.2 are H or halogen; R.sup.2, R.sup.3 and R.sup.4 may be the same or different and are independently H, metal ion, C.sub.1 to C.sub.8 alkyl or C.sub.3 to C.sub.12 alkenyl; X is O, S, NH or NCH.sub.2 R.sup.15 wherein R.sup.15 is H or C.sub.1 to C.sub.5 alkyl; and R.sup.1 is R.sup.5 --Q.sup.1 --Q.sup.2 --Q.sup.3 -- wherein R.sup.5, Q.sup.1, Q.sup.2 and Q.sup.3 are as defined herein; and when m is o, X is other than S; and if m is o and X is 0, then n is 1, 2, 3 or 4; including all stereoisomers thereof.
提供了抑制胆固醇生物合成(通过抑制新生角鲨烯生物合成)的化合物,因此可用作降胆固醇药物和抗动脉粥样硬化药物,其结构为##STR1##其中m为0、1、2或3;n为0、1、2、3或4;Y.sup.1和Y.sup.2为H或卤素;R.sup.2、R.sup.3和R.sup.4可以相同也可以不同,独立地为H、金属离子、C.sub.1到C.sub.8烷基或C.sub.3到C.sub.12烯基;X为O、S、NH或NCH.sub.2R.sup.15,其中R.sup.15为H或C.sub.1到C.sub.5烷基;R.sup.1为R.sup.5--Q.sup.1--Q.sup.2--Q.sup.3--其中R.sup.5、Q.sup.1、Q.sup.2和Q.sup.3如本文所定义;当m为o时,X不是S;如果m为o且X为0,则n为1、2、3或4;包括所有立体异构体。